1: Kojima SI, Kojima K, Fujita T. Investigation of 5-HT(3) receptor-triggered serotonin release from guinea-pig isolated colonic mucosa: a role of PYY-containing endocrine cell. Eur J Pharmacol. 2017 Mar 15;799:196-200. doi: 10.1016/j.ejphar.2017.02.011. Epub 2017 Feb 9. PubMed PMID: 28189582.
2: Riga MS, Sánchez C, Celada P, Artigas F. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission. Neuropharmacology. 2016 Sep;108:73-81. doi: 10.1016/j.neuropharm.2016.04.023. Epub 2016 Apr 20. PubMed PMID: 27106166.
3: Shimizu K, Kurosawa N, Seki K. The role of the AMPA receptor and 5-HT(3) receptor on aggressive behavior and depressive-like symptoms in chronic social isolation-reared mice. Physiol Behav. 2016 Jan 1;153:70-83. doi: 10.1016/j.physbeh.2015.10.026. Epub 2015 Nov 3. PubMed PMID: 26522741.
4: Leiser SC, Iglesias-Bregna D, Westrich L, Pehrson AL, Sanchez C. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism. J Psychopharmacol. 2015 Oct;29(10):1092-105. doi: 10.1177/0269881115592347. Epub 2015 Jul 14. PubMed PMID: 26174134; PubMed Central PMCID: PMC4579402.
5: Takimoto Y, Ishida Y, Nakamura Y, Kamakura T, Yamada T, Kondo M, Kitahara T, Uno A, Imai T, Horii A, Okazaki S, Nishiike S, Inohara H, Shimada S. 5-HT(3) receptor expression in the mouse vestibular ganglion. Brain Res. 2014 Apr 4;1557:74-82. doi: 10.1016/j.brainres.2014.02.016. Epub 2014 Feb 13. PubMed PMID: 24530269.
6: Höfelmann D, di Benedetto B, Azad SC, Micale V, Wotjak CT, Rammes G. Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments. Brain Res. 2013 Aug 21;1527:47-56. doi: 10.1016/j.brainres.2013.06.011. Epub 2013 Jun 19. PubMed PMID: 23791919.
7: Newman AS, Batis N, Grafton G, Caputo F, Brady CA, Lambert JJ, Peters JA, Gordon J, Brain KL, Powell AD, Barnes NM. 5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor. Br J Pharmacol. 2013 Jul;169(6):1228-38. doi: 10.1111/bph.12213. PubMed PMID: 23594147; PubMed Central PMCID: PMC3831704.
8: Oostland M, Sellmeijer J, van Hooft JA. Transient expression of functional serotonin 5-HT3 receptors by glutamatergic granule cells in the early postnatal mouse cerebellum. J Physiol. 2011 Oct 15;589(Pt 20):4837-46. doi: 10.1113/jphysiol.2011.217307. Epub 2011 Aug 30. PubMed PMID: 21878518; PubMed Central PMCID: PMC3224878.
9: Verheij MM, Veenvliet JV, Groot Kormelink T, Steenhof M, Cools AR. Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty. Psychopharmacology (Berl). 2009 Aug;205(3):441-55. doi: 10.1007/s00213-009-1552-1. Epub 2009 May 12. PubMed PMID: 19434397; PubMed Central PMCID: PMC2712066.
10: Ataka K, Kuge T, Fujino K, Takahashi T, Fujimiya M. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats. Auton Neurosci. 2007 May 30;133(2):136-45. Epub 2006 Dec 19. PubMed PMID: 17182287.
11: Abdel-Aziz H, Windeck T, Ploch M, Verspohl EJ. Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. Eur J Pharmacol. 2006 Jan 13;530(1-2):136-43. Epub 2005 Dec 20. PubMed PMID: 16364290.
12: Edwards E, Hampton E, Ashby CR, Zhang J, Wang RY. 5-HT3-like receptors in the rat medial prefrontal cortex: further pharmacological characterization. Brain Res. 1996 Sep 9;733(1):21-30. PubMed PMID: 8891244.